A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Chika Madu MD, Named Chair of Radiation Oncology at Staten Island University Hospital

Chika Madu MD has been appointed chair of Radiation Oncology at Staten Island University Hospital (SIUH).

In this new role, Dr. Madu will oversee all radiation oncology clinical care, research, and training programs.

Chika Madu MD joined SIUH as an Attending Physician in Radiation Medicine in 2015. Throughout her career, Dr. Madu has demonstrated her commitment to excellent clinical care, focusing on patient safety and quality improvement.

Devoted to medical education and research, Dr. Madu sees research as one of cornerstones of cancer care. In collaboration with the Northwell Health Cancer Institute, SIUH is making research a major part of cancer care services.

“Dr. Madu is a national leader in the field of radiation,” said Brahim Ardolic, MD, executive director of SIUH. “Her expertise, experience, and leadership will help bring an already exceptional department to even greater heights in caring for our patients, advancing research, and training the next generation of clinicians and scientists.”

An important tool in cancer treatment, radiation medicine offers the most comprehensive range of radiation therapy treatment programs on Staten Island, treating most types of cancer, including brain, head and neck, lung, breast, intestinal, bladder and prostate, sarcomas and pediatric tumors.

Dr. Madu currently serves as Chair of the Cancer Committee at SIUH, Chair of the Quality Management Committee for Radiation Medicine at SIUH, system-wide Radiation Medicine representative for the Northwell Health Physician Partners Quality Committee, and is also a member of SIUH Women in Medicine Executive committee.

“As the health care environment continues to shift, we are confident Dr. Madu will greatly influence our ability to evolve with the ever-changing demands in medicine,” explains Dr. Ardolic. “We have no doubt that her unique skills, energy and vision will propel the department to new heights.”

Dr. Madu received her Medical Degree from the University of Michigan Medical School and completed her residency in Radiation Oncology at the University of Pennsylvania. Following her training,

Dr. Madu joined the faculty at the Lombardi Cancer Center at Georgetown University Hospital where she served as Residency Program Director in the Department of Radiation Medicine and Assistant Professor at the Georgetown University School of Medicine. She is currently an Assistant Professor of Radiation Medicine at the Zucker School of Medicine at Hofstra/ Northwell.

Nationally, Dr. Madu also holds a leadership position within the American Society for Radiation Oncology’s CHEDI committee, where she serves as Co-lead in the Advocacy Working Group, aimed at eliminating barriers to minority enrollment into clinical trials.

Expanded care close to home 

SIUH is currently building the new Florina Cancer Center in response to the increasing prevalence of the disease on Staten Island, and the desire to improve outcomes through leading transformations in cancer care delivery and accelerating translational research.

Dr. Madu has been one of the key contributors to the state-of-the-art design and technology of the Center. She looks forward to engaging her team in working together towards organizational goals and fostering multidisciplinary collaboration for the optimal treatment and outcomes for cancer patients in our community.

“As our Cancer Center looks forward to the future, we are committed to maintaining our accreditations, and to providing safe, effective, high quality cancer care to our patients and their families,” said Chika Madu MD.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy